HDAC4 Inhibitors as Antivascular Senescence Therapeutics
Sign Up to like & getrecommendations! Published in 2022 at "Oxidative Medicine and Cellular Longevity"
DOI: 10.1155/2022/3087916
Abstract: Aging is an inevitable consequence of life, and during this process, the epigenetic landscape changes and reactive oxygen species (ROS) accumulation increases. Inevitably, these changes are common in many age-related diseases, including neurodegeneration, hypertension, and… read more here.
Keywords: hdac4 inhibitors; senescence therapeutics; antivascular senescence; hdac4 ... See more keywords